Calvert M, Freemantle N (2004) Research note: Use of health-related quality of life in prescribing research, part 1. Journal of Clinical Pharmacy & Therapeutics.
Brundage, M., Bass, B., Jolie, R., & Foley, K. (2011). A knowledge translation challenge: Clinical use of quality of life data from cancer clinical trials. Quality of Life Research,
Brundage, M., Leis, A., Bezjak, A., Feldman-Stewart, D., Degner, L., Velji, K., et al. (2003). Cancer patients’ preferences for communicating clinical trial quality of life information: A qualitative study. Quality of Life Research,
Lipscomb, J., Gotay, C. C., & Snyder, C. F. (2007). Patient-reported outcomes in cancer: A review of recent research and policy initiatives. CA: A Cancer Journal for Clinicians,
Osoba, D. (2005). The clinical value and meaning of health-related quality-of-life outcomes in oncology. In J. Lipscomb, C. C. Gotay, & C. Snyder (Eds.), Outcomes assessment in cancer (1st ed., pp. 386–405). Cambridge: Cambridge University Press.
Lemieux, J., Goodwin, P. J., Bordeleau, L. J., Lauzier, S., & Theberge, V. (2011). Quality-of-life measurement in randomized clinical trials in breast cancer: An updated systematic review (2001–2009). Journal of the National Cancer Institute,
Efficace, F., Bottomley, A., Osoba, D., Gotay, C., Flechtner, H., D’haese, S., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology,
Lee, C. W., & Chi, K. N. (2000). The standard of reporting of health-related quality of life in clinical cancer trials. Journal of Clinical Epidemiology,
Staquet, M., Berzon, R., Osoba, D., & Machin, D. (1996). Guidelines for reporting results of quality of life assessments in clinical trials. Quality of Life Research,
Brundage, M., Bass, B., Davidson, J., Queenan, J., Bezjak, A., Ringash, J., et al. (2011). Patterns of reporting health-related quality of life outcomes in randomized clinical trials: Implications for clinicians and quality of life researchers. Quality of Life Research,
Consolidated Standards of Reporting Trials (CONSORT) 2010. http://www.consort-statement.org.home.
Schulz, K. F., Altman, D. G., Moher, D., & CONSORT Group. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine,
MRC Hubs for Trials Methodology Research. http://www.methodologyhubs.mrc.ac.uk/about_us/hubs.aspx.
International Society for Quality of Life Research (ISOQOL) http://www.isoqol.org/2011.
Survey Monkey-Survey Development Software http://www.surveymonkey.com/.
MICROSOFT Excel software http://office.microsoft.com/en-ca/excel/.
Abbott, J., & Hart, A. (2005). Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: A critical review. Health & Quality of Life Outcomes,
Gill, T., & Feinstein, A. R. (1994). A critical appraisal of the quality of quality-of-life measurements. JAMA,
Joly, F., Vardy, J., Pintilie, M., & Tannock, I. F. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology,
Movsas, B. (2003). Quality of life in oncology trials: A clinical guide. Seminars in Radiation Oncology,
Street, J., Lenehan, B., & Fisher, C. (2009). The quality of quality of life publications in the spinal literature: Are we getting any better? Journal of Neurosurgery Spine,
Tanvetyanon, T., Soares, H. P., Djulbegovic, B., Jacobsen, P. B., & Bepler, G. (2007). A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer,
Temple, L., Fuzesi, S., & Patil, S. (2009). The importance of determining quality of life in clinical trials. Surgery,
Wiklund, I. (2004). Assessment of patient-reported outcomes in clinical trials: The example of health-related quality of life. Fundamental & Clinical Pharmacology,
Kong, S., & Gandhi, S. (1997). Methodologic assessments of quality of life measures in clinical trials. The Annals of Pharmacotherapy,
Revicki, D. A., Osoba, D., Fairclough, D., Barofsky, I., Berzon, R., Leidy, N. K., et al. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Quality of Life Research,
Revicki, D. A. (2005). Reporting analyses for clinical trials. In P. Fayers & R. D. Hays (Eds.), Assessing quality of life in clinical trials (2nd ed.). New York: Oxford University Press.
Sprangers, M. A., Moinpour, C. M., Moynihan, T. J., Patrick, D. L., & Revicki, D. A. (2002). Assessing meaningful change in quality of life over time: A users’ guide for clinicians. Mayo Clinic Proceedings,
European Medicines Agency. (2005). Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products.
The SPIRIT Initiative (Standard Protocol Items: Recommendations for Interventional trials). (2011). http://www.equator-network.org/resource-centre/library-of-health-research-reporting/reporting-guidelines-under-development/.
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010). Guidance for developers of health research reporting guidelines. PLoS Medicine/Public Library of Science,
Eysenbach, G. (2004). Improving the quality of Web surveys: The checklist for reporting results of internet E-surveys (CHERRIES). Journal of Medical Internet Research,